Ligand Pharmaceuticals LGND Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's other working capital?
- Ligand Pharmaceuticals (LGND) reported other working capital of -$547K in Q1 2026.
- How has Ligand Pharmaceuticals's other working capital changed year-over-year?
- Ligand Pharmaceuticals's other working capital decreased by 159.8% year-over-year, from $915K to -$547K.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.